STAT

Up and Down the Ladder: The latest comings and goings

Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. . Don’t be shy. Everyone

Vous lisez un aperçu, inscrivez-vous pour en lire plus.

Plus de STAT

STAT7 min de lecture
Inhumane Or Unavoidable? As Congress Scrutinizes An Increase In Monkey Research, Scientists Defend Its Necessity
Scientists are relying on monkey research more than ever before. And now Congress wants the NIH and FDA to explain why.
STAT6 min de lectureSociety
Opinion: Combatting Misinformation On Biosimilars And Preparing The Market For Them Can Save The U.S. Billions
For more than a decade, biosimilars have flourished in Europe. That hasn't happened in the U.S. because of misinformation and poor market preparation.
STAT3 min de lecturePolitics
With Eyes On Gilead, Lawmakers Want Details On How HHS Reviews Possible Patent Infringement
After a ruckus over a pricey Gilead Sciences drug for HIV, lawmakers want details on how HHS reviews possible patent infringement.